Literature DB >> 24602100

Greater loss of productivity among Japanese workers with gastro-esophageal reflux disease (GERD) symptoms that persist vs resolve on medical therapy.

H Suzuki1, J Matsuzaki, T Masaoka, J M Inadomi.   

Abstract

BACKGROUND: Gastro-esophageal reflux disease (GERD) impairs quality of life; however, the association between GERD and work productivity has not been well investigated in Japan. This study was designed to compare the impact of GERD on productivity between Japanese workers with GERD symptoms that persisted vs resolved on medical therapy.
METHODS: A cross-sectional Web-based survey was conducted in workers. The impact of GERD on work and daily productivity was evaluated using a Web-reported Work Productivity and Activity Impairment Questionnaire for patients with GERD and a GERD symptom severity Questionnaire. Demographic information, clinical history, and satisfaction with GERD medication were also ascertained. KEY
RESULTS: A total of 20 000 subjects were invited to the survey. After the exclusion of patients with a history of gastrointestinal (GI) malignancy, peptic ulcer, upper GI surgery, and unemployment, 650 participants were included in the analysis. Participants with persistent GERD symptoms reported a significantly greater losses of work productivity (11.4 ± 13.4 h/week), absenteeism (0.7 ± 3.1 h/week), presenteeism (10.7 ± 12.6 h/week), costs (20 100 ± 26 800 JPY/week), and lower daily productivity (71.3% [95% confidence interval, 69.0-73.7]) than those whose symptoms were alleviated with medications. The level of dissatisfaction with GERD medications among participants with persistent GERD symptoms was significantly correlated with loss of work and daily productivity (p < 0.001). CONCLUSIONS & INFERENCES: GERD places a significant burden on work and daily productivity despite medical therapy. Ineffective GERD therapy is associated with greater productivity loss.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  gastro-esophageal reflux disease; quality of life; treatment satisfaction; work productivity

Mesh:

Year:  2014        PMID: 24602100     DOI: 10.1111/nmo.12319

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  5 in total

1.  Mucosal breaks show same circumferential distribution in majority of patients with recurrent reflux esophagitis.

Authors:  Naoki Fukuda; Norihisa Ishimura; Mayumi Okada; Daisuke Izumi; Hironobu Mikami; Eiko Okimoto; Masahito Aimi; Tsuyoshi Mishiro; Naoki Oshima; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  Endosc Int Open       Date:  2017-03

2.  Effects of acotiamide on esophageal motor function and gastroesophageal reflux in healthy volunteers.

Authors:  Norihisa Ishimura; Mami Mori; Hironobu Mikami; Shino Shimura; Goichi Uno; Masahito Aimi; Naoki Oshima; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  BMC Gastroenterol       Date:  2015-09-11       Impact factor: 3.067

3.  Esophageal Motility and Rikkunshito Treatment for Proton Pump Inhibitor-Refractory Nonerosive Reflux Disease: A Prospective, Uncontrolled, Open-Label Pilot Study Trial.

Authors:  Takeo Odaka; Shigeru Yamato; Osamu Yokosuka
Journal:  Curr Ther Res Clin Exp       Date:  2017-04-04

4.  Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance.

Authors:  Hironobu Mikami; Norihisa Ishimura; Mayumi Okada; Daisuke Izumi; Eiko Okimoto; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  J Neurogastroenterol Motil       Date:  2018-04-30       Impact factor: 4.924

5.  Gastroesophageal reflux disease and its related factors among women of reproductive age: Korea Nurses' Health Study.

Authors:  Oksoo Kim; Hee Jung Jang; Sue Kim; Hea-Young Lee; Eunyoung Cho; Jung Eun Lee; Heeja Jung; Jiyoung Kim
Journal:  BMC Public Health       Date:  2018-09-21       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.